Literature DB >> 21410453

The calcium-sensing receptor and calcimimetics in blood pressure modulation.

Sanela Smajilovic1, Shozo Yano, Reza Jabbari, Jacob Tfelt-Hansen.   

Abstract

Calcium is a crucial second messenger in the cardiovascular system. However, calcium may also be an extracellular first messenger through a G-protein-coupled receptor that senses extracellular concentration (Ca(2+)(o)), the calcium-sensing receptor (CaR). The most prominent physiological function of the CaR is to maintain the extracellular Ca(2+) level in a very tight range by regulating the circulating levels of parathyroid hormone (PTH). This control over PTH and Ca(2+) levels is partially lost in patients suffering from primary and secondary hyperparathyroidism. Allosteric modulators of the CaR (calcimimetics) are the first drugs in their class to become available for clinical use and have been shown to successfully treat certain forms of primary and secondary hyperparathyroidism. In addition, several studies suggest beneficial effects of calcimimetics on cardiovascular risk factors associated with hyperparathyroidism. Although a plethora of studies demonstrated the CaR in heart and blood vessels, exact roles of the receptor in the cardiovascular system still remain to be elucidated. However, several studies point toward a possibility that the CaR might be involved in the regulation of vascular tone. This review will summarize the current knowledge on the possible functions of the CaR and calcimimetics on blood pressure regulation.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410453      PMCID: PMC3195912          DOI: 10.1111/j.1476-5381.2011.01317.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  88 in total

1.  Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs.

Authors:  Hiroki I Motoyama; Peter A Friedman
Journal:  Am J Physiol Renal Physiol       Date:  2002-09

Review 2.  Structure of the metabotropic glutamate receptor.

Authors:  Hisato Jingami; Shigetada Nakanishi; Kosuke Morikawa
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

3.  Parallel activation of phosphatidylinositol 4-kinase and phospholipase C by the extracellular calcium-sensing receptor.

Authors:  Chunfa Huang; Mary E Handlogten; R Tyler Miller
Journal:  J Biol Chem       Date:  2002-03-20       Impact factor: 5.157

Review 4.  The calcium-sensing receptor in human disease.

Authors:  Jacob Tfelt-Hansen; Peter Schwarz; Edward M Brown; Naibedya Chattopadhyay
Journal:  Front Biosci       Date:  2003-05-01

5.  Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells.

Authors:  J Tfelt-Hansen; R J MacLeod; N Chattopadhyay; S Yano; S Quinn; X Ren; E F Terwilliger; P Schwarz; E M Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04-15       Impact factor: 4.310

6.  Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.

Authors:  Hiroaki Ogata; Eberhard Ritz; Giulio Odoni; Kerstin Amann; Stephan R Orth
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

7.  Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients.

Authors:  Giuseppe Vezzoli; Annalisa Tanini; Luigi Ferrucci; Laura Soldati; Cristiana Bianchin; Francesco Franceschelli; Cecilia Malentacchi; Berardino Porfirio; Donatella Adamo; Annalisa Terranegra; Alberto Falchetti; Daniele Cusi; Giuseppe Bianchi; Maria Luisa Brandi
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

8.  Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.

Authors:  Sumiyo Watanabe; Seiji Fukumoto; Hangil Chang; Yasuhiro Takeuchi; Yukihiro Hasegawa; Ryo Okazaki; Noriko Chikatsu; Toshiro Fujita
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

9.  Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.

Authors:  Shozo Yano; Toshitsugu Sugimoto; Tatsuo Tsukamoto; Kazuo Chihara; Akira Kobayashi; Sohei Kitazawa; Sakan Maeda; Riko Kitazawa
Journal:  Eur J Endocrinol       Date:  2003-04       Impact factor: 6.664

10.  Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.

Authors:  Rosa Vargas-Poussou; Chunfa Huang; Philippe Hulin; Pascal Houillier; Xavier Jeunemaître; Michel Paillard; Gabrielle Planelles; Michèle Déchaux; R Tyler Miller; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  28 in total

1.  Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.

Authors:  Aya Yamamura; Qiang Guo; Hisao Yamamura; Adriana M Zimnicka; Nicole M Pohl; Kimberly A Smith; Ruby A Fernandez; Amy Zeifman; Ayako Makino; Hui Dong; Jason X-J Yuan
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

Review 2.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  The vascular endothelium: still amazing us 30 years on.

Authors:  C J Garland; A H Weston
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Lower serum calcium and pre-onset blood pressure elevation in cerebral hemorrhage patients undergoing hemodialysis.

Authors:  Mineaki Kitamura; Yohei Tateishi; Shuntaro Sato; Yuki Ota; Kumiko Muta; Tadashi Uramatsu; Tsuyoshi Izumo; Yasushi Mochizuki; Takashi Harada; Satoshi Funakoshi; Takayuki Matsuo; Akira Tsujino; Hideki Sakai; Hiroshi Mukae; Tomoya Nishino
Journal:  Clin Exp Nephrol       Date:  2020-01-14       Impact factor: 2.801

5.  Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: Results from CRIC study.

Authors:  Moshrik Abd Alamir; Vlad Radulescu; Michael Goyfman; Emile R Mohler; Yan Lin Gao; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2015-07-09       Impact factor: 5.162

Review 6.  Coronary artery calcification in chronic kidney disease: An update.

Authors:  Tomasz Stompór
Journal:  World J Cardiol       Date:  2014-04-26

7.  The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure.

Authors:  M Schepelmann; P L Yarova; I Lopez-Fernandez; T S Davies; S C Brennan; P J Edwards; A Aggarwal; J Graça; K Rietdorf; V Matchkov; R A Fenton; W Chang; M Krssak; A Stewart; K J Broadley; D T Ward; S A Price; D H Edwards; P J Kemp; D Riccardi
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-04       Impact factor: 4.249

8.  Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells.

Authors:  Aya Yamamura; Hisao Yamamura; Qiang Guo; Adriana M Zimnicka; Jun Wan; Eun A Ko; Kimberly A Smith; Nicole M Pohl; Shanshan Song; Amy Zeifman; Ayako Makino; Jason X-J Yuan
Journal:  Circ Res       Date:  2013-01-08       Impact factor: 17.367

9.  Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.

Authors:  A E Cook; S N Mistry; K J Gregory; S G B Furness; P M Sexton; P J Scammells; A D Conigrave; A Christopoulos; K Leach
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

10.  Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity.

Authors:  Natalie A Diepenhorst; Katie Leach; Andrew N Keller; Patricia Rueda; Anna E Cook; Tracie L Pierce; Cameron Nowell; Philippe Pastoureau; Massimo Sabatini; Roger J Summers; William N Charman; Patrick M Sexton; Arthur Christopoulos; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.